Pfizer And GSK Use Novel Funding Mechanism To Send Blockbuster Vaccines To World's Poorest Countries
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer and GSK have promised to supply 30 million doses each for the next 10 years. The first 20 percent of the supply will be sold for $7 per dose, while the remaining supply of Pfizer's Prevenar 13 and GSK's Synflorix will be sold for $3.50.